208 related articles for article (PubMed ID: 372791)
1. Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay system.
Clive D; Johnson KO; Spector JF; Batson AG; Brown MM
Mutat Res; 1979 Jan; 59(1):61-108. PubMed ID: 372791
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells.
DeMarini DM; Brock KH; Doerr CL; Moore MM
Mutat Res; 1987 Mar; 187(3):141-9. PubMed ID: 3821767
[TBL] [Abstract][Full Text] [Related]
3. Comparison of chromosome aberration frequency and small-colony TK-deficient mutant frequency in L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
Moore MM; Doerr CL
Mutagenesis; 1990 Nov; 5(6):609-14. PubMed ID: 2263219
[TBL] [Abstract][Full Text] [Related]
4. Procarbazine is a potent mutagen at the heterozygous thymidine kinase (tk +/-) locus of mouse lymphoma assay.
Clive D; Turner N; Krehl R
Mutagenesis; 1988 Mar; 3(2):83-7. PubMed ID: 3288842
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis at the ouabain-resistance locus of 3.7.2C L5178Y cells by chromosomal mutagens.
Amacher DE; Dunn EM
Environ Mutagen; 1985; 7(4):523-33. PubMed ID: 2996875
[TBL] [Abstract][Full Text] [Related]
6. Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt loci.
Moore MM; Harrington-Brock K; Doerr CL; Dearfield KL
Mutagenesis; 1989 Sep; 4(5):394-403. PubMed ID: 2687635
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic analysis of the L5178Y/TK+/- leads to TK-/- mouse lymphoma mutagenesis assay system.
Hozier J; Sawyer J; Moore M; Howard B; Clive D
Mutat Res; 1981 Nov; 84(1):169-81. PubMed ID: 7329431
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
Davies MJ; Phillips BJ; Rumsby PC
Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
[TBL] [Abstract][Full Text] [Related]
9. Mutagenicity of 2-amino-N6-hydroxyadenine (AHA) at three loci in L5178Y/tk+/- mouse lymphoma cells: molecular and preliminary cytogenetic characterizations of AHA-induced tk-/- mutants.
Clive D; Glover P; Krehl R; Poorman-Allen P
Mutat Res; 1991 Aug; 253(1):73-82. PubMed ID: 1651447
[TBL] [Abstract][Full Text] [Related]
10. Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/- mouse lymphoma cells.
Moore MM; Clive D; Hozier JC; Howard BE; Batson AG; Turner NT; Sawyer J
Mutat Res; 1985 Aug; 151(1):161-74. PubMed ID: 3927157
[TBL] [Abstract][Full Text] [Related]
11. Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
Harrington-Brock K; Collard DD; Chen T
Mutat Res; 2003 May; 537(1):21-8. PubMed ID: 12742504
[TBL] [Abstract][Full Text] [Related]
12. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. II. Test validation and interpretation.
Amacher DE; Paillet SC; Turner GN; Ray VA; Salsburg DS
Mutat Res; 1980 Aug; 72(3):447-74. PubMed ID: 7453708
[TBL] [Abstract][Full Text] [Related]
13. Methapyrilene is a genotoxic carcinogen: studies on methapyrilene and pyrilamine in the L5178Y/TK +/- mouse lymphoma assay.
Turner NT; Woolley JL; Hozier JC; Sawyer JR; Clive D
Mutat Res; 1987 Nov; 189(3):285-97. PubMed ID: 3670332
[TBL] [Abstract][Full Text] [Related]
14. Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing.
Amacher DE; Paillet S; Ray VA
Mutat Res; 1979 Dec; 64(6):391-406. PubMed ID: 392313
[TBL] [Abstract][Full Text] [Related]
15. Mutant frequencies and loss of heterozygosity induced by N-ethyl-N-nitrosourea in the thymidine kinase gene of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells.
Chen T; Harrington-Brock K; Moore MM
Mutagenesis; 2002 Mar; 17(2):105-9. PubMed ID: 11880538
[TBL] [Abstract][Full Text] [Related]
16. Ascorbate is detectably mutagenic in the L5178Y TK+/- cell mutation assay.
Amacher DE; Paillet SC
Cancer Lett; 1981 Nov; 14(2):151-8. PubMed ID: 7317878
[TBL] [Abstract][Full Text] [Related]
17. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
Clive D; Glover P; Applegate M; Hozier J
Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells by the clastogen ellipticine.
Moore MM; Brock KH; Doerr CL; DeMarini DM
Environ Mutagen; 1987; 9(2):161-70. PubMed ID: 3816714
[TBL] [Abstract][Full Text] [Related]
19. Specific gene mutations in L5178Y cells in culture.
Clive D; McCuen R; Spector JF; Piper C; Mavournin KH
Mutat Res; 1983 Jun; 115(2):225-51. PubMed ID: 6855786
[TBL] [Abstract][Full Text] [Related]
20. A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay.
Wang J; Heflich RH; Moore MM
Mutat Res; 2007 Jan; 626(1-2):185-90. PubMed ID: 17055776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
